160 related articles for article (PubMed ID: 36761898)
21. Impact of FIB-4 index on hepatocellular carcinoma incidence during nucleos(t)ide analogue therapy in patients with chronic hepatitis B: An analysis using time-dependent receiver operating characteristic.
Tada T; Kumada T; Toyoda H; Tsuji K; Hiraoka A; Tanaka J
J Gastroenterol Hepatol; 2017 Feb; 32(2):451-458. PubMed ID: 27288655
[TBL] [Abstract][Full Text] [Related]
22. Serum PIVKA-II and alpha-fetoprotein at virological remission predicts hepatocellular carcinoma in chronic hepatitis B related cirrhosis.
Su TH; Peng CY; Chang SH; Tseng TC; Liu CJ; Chen CL; Liu CH; Yang HC; Chen PJ; Kao JH
J Formos Med Assoc; 2022 Mar; 121(3):703-711. PubMed ID: 34452785
[TBL] [Abstract][Full Text] [Related]
23. Predicting clinical outcomes in patients with HBsAg-positive chronic hepatitis.
Tong MJ; Huynh TT; Siripongsakun S; Chang PW; Tong LT; Ha YP; Mena EA; Weissman MF
Hepatol Int; 2015 Oct; 9(4):567-77. PubMed ID: 26219830
[TBL] [Abstract][Full Text] [Related]
24. A comparison of clinical pathologic characteristics between alpha-fetoprotein negative and positive hepatocellular carcinoma patients from Eastern and Southern China.
Chi X; Jiang L; Yuan Y; Huang X; Yang X; Hochwald S; Liu J; Huang H
BMC Gastroenterol; 2022 Apr; 22(1):202. PubMed ID: 35461226
[TBL] [Abstract][Full Text] [Related]
25. Clinical course of chronic hepatitis B (CHB) presented with normal ALT in Asian American patients.
Nguyen K; Pan C; Xia V; Hu J; Hu KQ
J Viral Hepat; 2015 Oct; 22(10):809-16. PubMed ID: 25611883
[TBL] [Abstract][Full Text] [Related]
26. Clinical features of hepatitis B and C virus infections, with high α-fetoprotein levels but not hepatocellular carcinoma.
Kim CY; Kim BR; Lee SS; Jeon DH; Lee CM; Kim WS; Cho HC; Kim JJ; Lee JM; Kim HJ; Ha CY; Kim HJ; Kim TH; Jung WT; Lee OJ
Medicine (Baltimore); 2017 Jan; 96(2):e5844. PubMed ID: 28079817
[TBL] [Abstract][Full Text] [Related]
27. A predictive model for carcinogenesis in patients with chronic hepatitis B undergoing entecavir therapy and its validation.
Nishikawa H; Nishijima N; Enomoto H; Sakamoto A; Nasu A; Komekado H; Nishimura T; Kita R; Kimura T; Iijima H; Nishiguchi S; Osaki Y
Medicine (Baltimore); 2016 Sep; 95(36):e4832. PubMed ID: 27603400
[TBL] [Abstract][Full Text] [Related]
28. Oral antiviral therapy improves the diagnostic accuracy of alpha-fetoprotein levels in patients with chronic hepatitis B.
Shim JJ; Kim JW; Lee CK; Jang JY; Kim BH
J Gastroenterol Hepatol; 2014 Sep; 29(9):1699-705. PubMed ID: 24730702
[TBL] [Abstract][Full Text] [Related]
29. On-treatment alpha-fetoprotein is a specific tumor marker for hepatocellular carcinoma in patients with chronic hepatitis B receiving entecavir.
Wong GL; Chan HL; Tse YK; Chan HY; Tse CH; Lo AO; Wong VW
Hepatology; 2014 Mar; 59(3):986-95. PubMed ID: 24123097
[TBL] [Abstract][Full Text] [Related]
30. Analysis on the value of soluble intercellular adhesion molecule-1 (sICAM-1), alpha fetoprotein (AFP), and aspartate aminotransferase/platelet ratio index (APRI) in predicting the prognostic survival of patients with primary liver cancer after radiofrequency ablation.
Guo C; Liang H; Yuan W; Qin Y
Ann Palliat Med; 2021 Apr; 10(4):4760-4767. PubMed ID: 33966425
[TBL] [Abstract][Full Text] [Related]
31. Clinical significance of elevated alpha-fetoprotein in Alaskan Native patients with chronic hepatitis C.
Bruce MG; Bruden D; McMahon BJ; Christensen C; Homan C; Sullivan D; Deubner H; Williams J; Livingston SE; Gretch D
J Viral Hepat; 2008 Mar; 15(3):179-87. PubMed ID: 18233991
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of Serum α-Fetoprotein Levels During Different Infection Phases of CHB Patients.
Yang N; Feng J; Li ZR; Ming KH; Lei XX; Xu BL
Clin Lab; 2018 Jan; 64(1):43-49. PubMed ID: 29479896
[TBL] [Abstract][Full Text] [Related]
33. Dynamic α-fetoprotein, platelets and AST-to-platelet ratio index predict hepatocellular carcinoma in chronic hepatitis C patients with sustained virological response after antiviral therapy.
Wu CK; Chang KC; Hung CH; Tseng PL; Lu SN; Chen CH; Wang JH; Lee CM; Tsai MC; Lin MT; Yen YH; Hu TH
J Antimicrob Chemother; 2016 Jul; 71(7):1943-7. PubMed ID: 27073265
[TBL] [Abstract][Full Text] [Related]
34. Higher Ratio of Serum Alpha-Fetoprotein Could Predict Outcomes in Patients with Hepatitis B Virus-Associated Hepatocellular Carcinoma and Normal Alanine Aminotransferase.
Kim YI; Kim HS; Park JW
PLoS One; 2016; 11(6):e0157299. PubMed ID: 27304617
[TBL] [Abstract][Full Text] [Related]
35. Serum alpha-fetoprotein levels in patients with advanced hepatitis C: results from the HALT-C Trial.
Di Bisceglie AM; Sterling RK; Chung RT; Everhart JE; Dienstag JL; Bonkovsky HL; Wright EC; Everson GT; Lindsay KL; Lok AS; Lee WM; Morgan TR; Ghany MG; Gretch DR;
J Hepatol; 2005 Sep; 43(3):434-41. PubMed ID: 16136646
[TBL] [Abstract][Full Text] [Related]
36. Risk factors for hepatocellular carcinoma in patients with drug-resistant chronic hepatitis B.
Jun CH; Hong HJ; Chung MW; Park SY; Cho SB; Park CH; Joo YE; Kim HS; Choi SK; Rew JS
World J Gastroenterol; 2013 Oct; 19(40):6834-41. PubMed ID: 24187458
[TBL] [Abstract][Full Text] [Related]
37. High Post-treatment α-Fetoprotein Levels and Aspartate Aminotransferase-to-Platelet Ratio Index Predict Hepatocellular Carcinoma in Hepatitis C Virus Decompensated Cirrhotic Patients with Sustained Virological Response After Antiviral Therapy.
Ji F; Zhou R; Wang W; Bai D; He C; Cai Z; Shen Y; Wang S; Deng H; Li Z
J Interferon Cytokine Res; 2017 Aug; 37(8):362-368. PubMed ID: 28731786
[TBL] [Abstract][Full Text] [Related]
38. Effects of radiofrequency ablation combined with transarterial chemoembolization and antiviral therapy on the prognosis and quality of life in primary chronic HBV-related liver cancer.
Lu B; Zhu L; Wang X; Zhong L; Cheng Y; Fan J; Yu L
J BUON; 2019; 24(5):1979-1984. PubMed ID: 31786864
[TBL] [Abstract][Full Text] [Related]
39. Validation of FIB-4 and comparison with other simple noninvasive indices for predicting liver fibrosis and cirrhosis in hepatitis B virus-infected patients.
Kim BK; Kim DY; Park JY; Ahn SH; Chon CY; Kim JK; Paik YH; Lee KS; Park YN; Han KH
Liver Int; 2010 Apr; 30(4):546-53. PubMed ID: 20074094
[TBL] [Abstract][Full Text] [Related]
40. The Expressions of CD44, CD90 and Alpha Fetoprotein Biomarkers in Indonesian Patients with Advanced Liver Disease: an Observational Study.
Mustika S; Wijaya H; Pratomo B
Acta Med Indones; 2019 Apr; 51(2):137-144. PubMed ID: 31383828
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
